Back

5Q Spectra advances PSB blood test toward global adoption with 2027 trial

Verifying
  • 5Q Spectra will introduce the next phase of its PSB prostate cancer blood-test program.
  • More than 1,000 patients are expected to join the randomized study planned for early 2027.
  • The test is currently available through CLIA-certified laboratories as a Laboratory Developed Test.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.